𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumour regressions with novel prodrugs in antibody-directed enzyme prodrug therapy (ADEPT)

✍ Scribed by Springer, C.J.; Burke, P.J.; Blakey, D.C.; Davies, D.H.; Dowell, R.I.; Melton, R.

Book ID
122624688
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
113 KB
Volume
30
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antibody-directed enzyme prodrug therapy
Antibody-directed enzyme prodrug therapy (ADEPT)
✍ Sharma, Surinder K. ;Boden, Joan A. ;Springer, Caroline J. ;Burke, Philip J. ;Ba πŸ“‚ Article πŸ“… 1994 πŸ› Springer-Verlag 🌐 English βš– 612 KB
A novel enediyne prodrug for antibody-di
A novel enediyne prodrug for antibody-directed enzyme prodrug therapy (ADEPT) using E. coli B nitroreductase
✍ M.P. Hay; W.R. Wilson; W.A. Denny πŸ“‚ Article πŸ“… 1995 πŸ› Elsevier Science 🌐 English βš– 256 KB

The synthesis of a novel enediyne 2, and its cytotoxicity and activation by the nitroreductase enzyme NR2 from Esherichia coli B, are described. In contrast to closely related analogues, 2 exhibits a 90-fold increase in cytotoxicity against UV4 cells in the presence of the enzyme and NADH, suggestin